Blood markers may foretell heart danger in diabetes patients

NCT ID NCT06902857

Ongoing Knowledge-focused Sponsor: Istituto Nazionale di Ricovero e Cura per Anziani Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is following 964 people with type 2 diabetes to see if three blood markers (hs-cTnI, NT-proBNP, and sST2) can predict who will die or have heart problems. Participants gave blood samples and are being tracked for years. No treatment is being tested—the goal is to learn whether these markers can help doctors spot high-risk patients earlier.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could help doctors identify type 2 diabetes patients at higher risk for heart problems or death, allowing earlier preventive care.
What could go wrong: This is an observational study, not a treatment trial. It only measures markers and cannot prove cause or improve outcomes directly. Results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CARDIOVASCULAR COMPLICATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cardiovascular disorder Diabetes Complications type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CARDIOVASCULAR COMPLICATION TYPE 2 DIABETES

Contacts and locations

Locations

IRCCS INRCA Hospital

Ancona, 60127, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.